Syngene International Limited
SYNGENE · 539268 · Healthcare · Healthcare Research, Analytics & Technology
- Market cap
- Rs 14,747 Cr
- P/E
- 66.42x
- P/B
- 3.05x
- 52W high / low
- Rs 678.95 / Rs 360.4
Our computed operating_margin (9.37%) diverges from BSE's own published figure (31.09%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (6.14%) diverges from BSE's own published figure (15.44%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Healthcare Research, Analytics & Technology. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Syngene International LimitedThis company | Rs 365.3 | Rs 14,747 Cr | Rs 3,679 Cr | Rs 221 Cr | 66.42x | 4.62% |
| Indegene Limited | Rs 590.75 | Rs 14,208 Cr | Rs 3,892 Cr | Rs 401 Cr | 35.35x | 10.39% |
| Suven Life Sciences Limited | Rs 320.2 | Rs 8,453 Cr | Rs 29.7 Cr | Rs -352.4 Cr | — | -100.50% |
| Median | Rs 590.75 | Rs 14,208 Cr | Rs 3,892 Cr | Rs 401 Cr | 35.35x | 10.39% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.